Ratings by UBS (Douglas Schenkel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 11/4/2026 | Stevanato Group S.p.A. | STVN | Maintain | Neutral (Neutral) |
|
Details | ||
| 10/22/2026 | Thermo Fisher Scientific | TMO | Maintain | Buy (Buy) |
|
Details | ||
| 10/22/2026 | Danaher | DHR | Maintain | Buy (Buy) |
|
Details | ||
| 9/29/2026 | Repligen | RGEN | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2026 | Veracyte, Inc | VCYT | Maintain | Buy (Buy) |
|
Details | ||
| 9/9/2026 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
64.29 (75.61) |
17.61% | Details | |
| 9/9/2026 | Natera | NTRA | New Coverage | Buy (N/A) |
324.14 (391.03) |
20.64% | Details | |
| 9/9/2026 | Myriad Genetics | MYGN | New Coverage | Neutral (N/A) |
3.18 (6.02) |
89.31% | Details | |
| 9/9/2026 | HeartFlow | HTFL | New Coverage | Neutral (N/A) |
47.75 (56.57) |
18.47% | Details | |
| 9/9/2026 | Guardant Health | GH | New Coverage | Buy (N/A) |
160.98 (168.58) |
4.72% | Details | |
| 9/9/2026 | GRAIL, Inc. | GRAL | New Coverage | Buy (N/A) |
79.10 (143.66) |
81.62% | Details | |
| 9/9/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
24.82 (33.22) |
33.84% | Details | |
| 9/9/2026 | West Pharmaceutical | WST | New Coverage | Buy (N/A) |
337.75 (408.78) |
21.03% | Details | |
| 9/9/2026 | Stevanato Group S.p.A. | STVN | New Coverage | Neutral (N/A) |
20.32 (13.44) |
-33.86% | Details | |
| 9/9/2026 | Twist Bioscience | TWST | New Coverage | Neutral (N/A) |
128.06 (142.58) |
11.34% | Details | |
| 9/9/2026 | Pacific Biosciences of California | PACB | New Coverage | Neutral (N/A) |
1.32 (2.55) |
93.18% | Details | |
| 9/9/2026 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
65.60 (67.52) |
2.93% | Details | |
| 9/9/2026 | Repligen | RGEN | New Coverage | Buy (N/A) |
168.53 (178.20) |
5.74% | Details | |
| 9/9/2026 | Maravai LifeScience Holdings Inc. | MRVI | Maintain | Neutral (N/A) |
|
Details | ||
| 9/9/2026 | Revvity Inc | RVTY | New Coverage | Neutral (N/A) |
127.08 (159.43) |
25.46% | Details | |
| 9/9/2026 | Qiagen NV | QGEN | New Coverage | Neutral (N/A) |
42.38 (50.83) |
19.94% | Details | |
| 9/9/2026 | Waters Corp. | WAT | New Coverage | Buy (N/A) |
402.91 (467.60) |
16.06% | Details | |
| 9/9/2026 | Mettler-Toledo | MTD | New Coverage | Neutral (N/A) |
1325.52 (1723.24) |
30% | Details | |
| 9/9/2026 | Illumina | ILMN | New Coverage | Buy (N/A) |
211.06 (226.54) |
7.33% | Details | |
| 9/9/2026 | Bruker | BRKR | New Coverage | Neutral (N/A) |
58.37 (63.79) |
9.29% | Details | |
| 9/9/2026 | Avantor Inc. | AVTR | New Coverage | Neutral (N/A) |
15.25 (15.65) |
2.62% | Details | |
| 9/9/2026 | Agilent | A | New Coverage | Neutral (N/A) |
146.85 (177.17) |
20.65% | Details | |
| 9/9/2026 | Thermo Fisher Scientific | TMO | Upgrade | Buy (Neutral) |
613.78 (706.16) |
15.05% | Details | |
| 9/9/2026 | Danaher | DHR | New Coverage | Buy (N/A) |
207.66 (234.93) |
13.13% | Details |
